DOI:
10.1055/s-00000009
American Journal of Perinatology
LinksClose Window
References
Feltes TF, Sondheimer HM, Tulloh RM. , et al; Motavizumab Cardiac Study Group.
A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease.
Pediatr Res 2011;
70 (02) 186-191
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.